The therapies targeting mutations of driver genes in cancer have advanced into clinical trials
for a variety of tumors. In glioblastoma (GBM), epidermal growth factor receptor (EGFR) is …

Introduction Histological images contain phenotypic information predictive of patient
outcomes. Due to the heavy workload of pathologists, the time-consuming nature of …

Abstract Background: PreciseDx Breast is a digital test that predicts early-stage breast
cancer recurrence within 6-years of diagnosis. Materials and Methods: Using hematoxylin …

Multigene prognostic genomic assays have become essential tools in the management of
early breast cancer (BC), providing information that help in risk-stratification, to provide risk …

Background Nottingham histological grade (NHG) is a well established prognostic factor in
breast cancer histopathology but has a high inter-assessor variability with many tumours …

Metastatic prostate cancer remains an incurable lethal disease. Studies indicate that
prostate cancer accumulates genomic changes during disease progression and displays the …

Prognostic markers in routine clinical management of breast cancer are often assessed
using RNA-based multi-gene panels that depend on fluctuating tumor purity. Multiplex …

Aims Use of gene expression signatures to predict adjuvant chemotherapy benefit in women
with early-stage breast cancer is increasing. However, high cost, limited access, and …

Background Invasive micropapillary carcinoma (IMPC) of the breast is a rare subtype of
breast cancer with high incidence of aggressive clinical behavior, lymph node metastasis …

This paper addresses the vital task of diagnosing breast cancer early and accurately. It
acknowledges the difficulty in detecting minor variations in breast cancer patterns through …